CDK12 loss leads to replication stress and sensitivity to combinations of the ATR inhibitor camonsertib (RP-3500) with PARP inhibitors

J. Setton,D. Gallo,D. Glodzik, B. Kaiser, S. Braverman, T. Ubhi, S. Fournier,P. Selenica, N. Laterreur,A. Roulston, G. Brown, S. Morris, J. Reis-Filho, M. Zimmermann

European Journal of Cancer(2022)

引用 0|浏览11
暂无评分
关键词
atr inhibitor camonsertib,parp inhibitors,replication stress
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要